4.5 Article

Amyotrophic lateral sclerosis: Is the spinal fluid pathway involved in seeding and spread?

Journal

MEDICAL HYPOTHESES
Volume 85, Issue 5, Pages 576-583

Publisher

CHURCHILL LIVINGSTONE
DOI: 10.1016/j.mehy.2015.07.014

Keywords

-

Funding

  1. Amyotrophic Lateral Sclerosis Association
  2. NIH/NINDS
  3. Iron Horse Diagnostics, Inc.
  4. Knopp Biosciences, LLC.

Ask authors/readers for more resources

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder manifested primarily by loss of upper and lower motor neurons. Current explanations for disease progression invoke regional spread attributed to the transfer of pathogenic factors among physically contiguous neurons. However, this explanation incompletely explains certain clinical and in vitro data. Considering this, we propose that the cerebrospinal fluid (CSF) pathway is likely to be a key vector for seeding local and distal disease. Subsequent disease progression would be expected to occur independently via either axonal or CSF transmission. If one accepts the hypothesis that the CSF pathway is involved in ALS progression, it follows that the choroid plexus (CP) might well be a driver of the disease process. In support of this, we briefly review the anatomical and physiological features of the CSF pathway and the choroid plexus responsible for secreting CSF. In addition, we draw attention to the interface of the CP and CSF with the immune system. We then summarize both clinical and cell culture research that supports a key role of the CSF in the establishment and inter-neuronal spread of ALS, and which suggest directions for translational research. (C) 2015 The Authors. Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial

Richard Smith, Erik Pioro, Kathleen Myers, Michael Sirdofsky, Kimberly Goslin, Gregg Meekins, Hong Yu, James Wymer, Merit Cudkowicz, Eric A. Macklin, David Schoenfeld, Gary Pattee

NEUROTHERAPEUTICS (2017)

Article Clinical Neurology

Assessment of bulbar function in amyotrophic lateral sclerosis: validation of a self-report scale (Center for Neurologic Study Bulbar Function Scale)

R. A. Smith, E. A. Macklin, K. J. Myers, G. L. Pattee, K. L. Goslin, G. D. Meekins, J. R. Green, J. M. Shefner, E. P. Pioro

EUROPEAN JOURNAL OF NEUROLOGY (2018)

Article Rehabilitation

Magnetic source imaging of cortical dysfunction in amyotrophic lateral sclerosis

Robert A. Boyajian, Carlos Arno, Shirley M. Otis, John S. Romine, Richard A. Smith

AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2008)

Article Biochemistry & Molecular Biology

Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment

Merrill D. Benson, Richard A. Smith, Gene Hung, Barbara Kluve-Beckerman, Aaron D. Showalter, Kyle W. Sloop, Brett P. Monia

AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2010)

Review Clinical Neurology

Gene-targeted therapies for the central nervous system

Timothy M. Miller, Richard A. Smith, Holly Kordasiewicz, Brian K. Kaspar

ARCHIVES OF NEUROLOGY (2008)

Article Pharmacology & Pharmacy

Additional evidence for a therapeutic effect of dextromethorphan/quinidine on bulbar motor function in patients with amyotrophic lateral sclerosis: A quantitative speech analysis

Jordan R. Green, Kristen M. Allison, Claire Cordella, Brian D. Richburg, Gary L. Pattee, James D. Berry, Eric A. Macklin, Erik P. Pioro, Richard A. Smith

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)

Article Multidisciplinary Sciences

Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS

Kathrin Meyer, Laura Ferraiuolo, Carlos J. Miranda, Shibi Likhite, Sohyun McElroy, Samantha Renusch, Dara Ditsworth, Clotilde lagier-Tourenne, Richard A. Smith, John Ravits, Arthur H. Burghes, Pamela J. Shaw, Don W. Cleveland, Stephen J. Kolb, Brian K. Kaspar

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Clinical Neurology

An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study

Timothy M. Miller, Alan Pestronk, William David, Jeffrey Rothstein, Ericka Simpson, Stanley H. Appel, Patricia L. Andres, Katy Mahoney, Peggy Allred, Katie Alexander, Lyle W. Ostrow, David Schoenfeld, Eric A. Macklin, Daniel A. Norris, Georgios Manousakis, Matthew Crisp, Richard Smith, C. Frank Bennett, Kathie M. Bishop, Merit E. Cudkowicz

LANCET NEUROLOGY (2013)

Review Pharmacology & Pharmacy

Dextromethorphan/quinidine: a novel dextromethorphan product for the treatment of emotional lability

Richard Alan Smith

EXPERT OPINION ON PHARMACOTHERAPY (2006)

Article Medicine, Research & Experimental

Antisense oligonucleotide therapy for neurodegenerative disease

Richard A. Smith, Timothy M. Miller, Koji Yamanaka, Brett P. Monia, Thomas F. Condon, Gene Hung, Christian S. Lobsiger, Chris M. Ward, Melissa McAlonis-Downes, Hongbing Wei, Ed V. Wancewicz, C. Frank Bennett, Don W. Cleveland

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Clinical Neurology

Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis

HS Panitch, RA Thisted, RA Smith, DR Wynn, JP Wymer, A Achiron, TL Vollmer, RN Mandler, DW Dietrich, M Fletcher, LE Pope, JE Berg, A Miller

ANNALS OF NEUROLOGY (2006)

Article Clinical Neurology

Treatment of pseudobulbar affect in ALS with dextromethorphan/quinidine - A randomized trial

BR Brooks, RA Thisted, SH Appel, WG Bradley, RK Olney, JE Berg, LE Pope, RA Smith

NEUROLOGY (2004)

Article Clinical Neurology

Measuring pseudobulbar affect in ALS

RA Smith, JE Berg, LE Pope, RA Thisted

AMYOTROPHIC LATERAL SCLEROSIS AND OTHER MOTOR NEURON DISORDERS (2004)

Article Clinical Neurology

Validation of the CNS emotional lability scale for pseudobulbar affect (pathological laughing and crying) in multiple sclerosis patients

RA Smith, JE Berg, LE Pope, JD Callahan, D Wynn, RA Thisted

MULTIPLE SCLEROSIS JOURNAL (2004)

Article Medicine, Research & Experimental

Alleviating morphine-induced itching while sustaining its analgesic efficacy: Esketamine as a potential co-administrating choice

Tong Cheng, Zhusheng Chen, Yibin Qin, Xiang Zhu, Hongsheng Chen, Zhongling Xu, Xiaqing Ma

Summary: Morphine is commonly used and effective for pain relief, but its side effect of itching limits its clinical use. This paper discusses the potential of using esketamine to treat morphine-induced itching.

MEDICAL HYPOTHESES (2024)

Article Medicine, Research & Experimental

Hyperbaric oxygen therapy as a possible therapeutic candidate for sepsis-associated encephalopathy: A novel hypothesis

Sung Eun Lee, Eunjung Park, Ji-yun Kim, HyukHoon Kim

Summary: Hyperbaric oxygen therapy (HBOT) is a potential therapeutic modality that has been recognized for its favorable mechanisms in various diseases, including sepsis-associated encephalopathy (SAE). HBOT has neuroprotective effects through its anti-inflammatory and antiapoptotic effects as well as increased tissue oxygenation capacity. However, there are caveats and limitations in applying HBOT in sepsis.

MEDICAL HYPOTHESES (2024)